Market Overview

Anti-CD37 Antibody Pipeline Insight, 2018 Report - ResearchAndMarkets.com

Share:

The "Anti-CD37
Antibody - Pipeline Insight, 2018"
drug pipelines has been
added to ResearchAndMarkets.com's offering.

'Anti-CD37 Antibody - Pipeline Insight, 2018' report offers
comprehensive insights of the pipeline (under development) therapeutics
scenario and growth prospects across Anti-CD37 Antibody development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Descriptive coverage of pipeline development activities for Anti-CD37
Antibody - Pipeline therapeutics development coverage provides
descriptive product profiles including (but not limited to) drug
description, product development and R&D activities encompassing
clinical and pre-clinical studies, designations, collaborations,
licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. Anti-CD37 Antibody - Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Anti-CD37 Antibody

4. Comparative Analysis

5. Anti-CD37 Antibody Pipeline Products in Clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

Other product profiles in the detailed report..

6. Anti-CD37 Antibody Pipeline Products in Non-clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment: Active Products

  • Pipeline Assessment by Route of Administration
  • Pipeline Assessment by Stage and Route of Administration
  • Pipeline Assessment by Molecule Type
  • Pipeline Assessment by Stage and Molecule Type

8. Inactive Pipeline Products

  • Product Description
  • Research and Development
  • Product Development Activities
  • Reason for dormancy/discontinuation

Companies Mentioned

  • Nordic Nanovector
  • ImmunoGen
  • Boehringer Ingelheim

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/9c5w6m/anticd37?w=4

View Comments and Join the Discussion!